No Data
No Data
The Price Is Right For Guangdong Taienkang Pharmaceutical Co., Ltd. (SZSE:301263)
Taenker (301263.SZ): The application for the listing of 'Piracetam Tablets' has been accepted.
Tiankang (301263.SZ) announced that its wholly-owned subsidiary Anhui Tiankang Pharmaceutical Co., Ltd. recently received a notice from the national...
Taikang (301263.SZ): Cumulative repurchase of 0.47% of shares.
On September 2, Gelonhui announced that as of August 31, 2024, the company had repurchased a total of 1,985,118 shares through the Shenzhen Stock Exchange trading system using centralized bidding trading method, accounting for 0.4665% of the total share capital. The highest repurchase price was 20.12 yuan/share, and the lowest price was 18.56 yuan/share, with a total amount of RMB 38.9869 million paid (excluding transaction fees).
Taienkang: 2024 Semi-Annual Report
Taienkang: 2024 Semi-Annual Report Summary
After the Recent Decline, Guangdong Taienkang Pharmaceutical Co., Ltd. (SZSE:301263) CEO Hanjie Zheng's Holdings Have Lost 6.2% of Their Value
No Data
No Data